{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T12:09:39Z","timestamp":1724501379286},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T00:00:00Z","timestamp":1347494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s13277-012-0509-x","type":"journal-article","created":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T07:52:48Z","timestamp":1347436368000},"page":"47-53","source":"Crossref","is-referenced-by-count":10,"title":["A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population"],"prefix":"10.1007","volume":"34","author":[{"given":"Fei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lvnan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianfu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,13]]},"reference":[{"key":"509_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"509_CR2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","volume":"6","author":"PA Farazi","year":"2006","unstructured":"Farazi PA, Depinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev. 2006;6:674\u201387.","journal-title":"Nat Rev"},{"key":"509_CR3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1440-1746.2009.05784.x","volume":"24","author":"MF Yuen","year":"2009","unstructured":"Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009;24:346\u201353.","journal-title":"J Gastroenterol Hepatol"},{"key":"509_CR4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","volume":"2","author":"DM Parkin","year":"2001","unstructured":"Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533\u201343.","journal-title":"Lancet Oncol"},{"key":"509_CR5","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.22580","volume":"48","author":"RN Aravalli","year":"2008","unstructured":"Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology. 2008;48:2047\u201363.","journal-title":"Hepatology"},{"key":"509_CR6","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1053\/jhep.2002.37084","volume":"36","author":"CJ Chen","year":"2002","unstructured":"Chen CJ, Chen DS. Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. Hepatology. 2002;36:1046\u20139.","journal-title":"Hepatology"},{"issue":"5 Suppl.2","key":"509_CR7","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/00004836-200211002-00003","volume":"35","author":"NN Nissen","year":"2002","unstructured":"Nissen NN, Martin P. Hepatocellular carcinoma: the high-risk patient. J Clin Gastroenterol. 2002;35(5 Suppl2):S79\u201385.","journal-title":"J Clin Gastroenterol"},{"key":"509_CR8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","volume":"436","author":"DG Bowen","year":"2005","unstructured":"Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature. 2005;436:946\u201352.","journal-title":"Nature"},{"key":"509_CR9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.20860","volume":"42","author":"N Kato","year":"2005","unstructured":"Kato N, Ji G, Wang Y, et al. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C. Hepatology. 2005;42:846\u201353.","journal-title":"Hepatology"},{"key":"509_CR10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000082089","volume":"48","author":"YJ Kim","year":"2005","unstructured":"Kim YJ, Lee HS. Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Intervirology. 2005;48:10\u20135.","journal-title":"Intervirology"},{"key":"509_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-2952(00)00321-X","volume":"60","author":"P Joseph","year":"2000","unstructured":"Joseph P, Long DJ, Klein-Szanto AJ, Jaiswal AK. Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity. Biochem Pharmacol. 2000;60:207\u201314.","journal-title":"Biochem Pharmacol"},{"key":"509_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cbi.2005.03.019","volume":"153\u2013154","author":"K Iskander","year":"2005","unstructured":"Iskander K, Jaiswal AK. Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity. Chem Biol Interact. 2005;153\u2013154:147\u201357.","journal-title":"Chem Biol Interact"},{"key":"509_CR13","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1124\/mol.65.5.1238","volume":"65","author":"D Siegel","year":"2004","unstructured":"Siegel D, Gustafson DL, Dehn DL, et al. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol. 2004;65:1238\u201347.","journal-title":"Mol Pharmacol"},{"key":"509_CR14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.abb.2010.03.019","volume":"501","author":"AT Dinkova-Kostova","year":"2010","unstructured":"Dinkova-Kostova AT, Talalay P. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys. 2010;501:116\u201323.","journal-title":"Arch Biochem Biophys"},{"key":"509_CR15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1101\/gad.319905","volume":"19","author":"G Asher","year":"2005","unstructured":"Asher G, Tsvetkov P, Kahana C, Shaul Y. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. 2005;19:316\u201321.","journal-title":"Genes Dev"},{"key":"509_CR16","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.052706799","volume":"99","author":"G Asher","year":"2002","unstructured":"Asher G, Lotem J, Kama R, Sachs L, Shaul Y. NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A. 2002;99:3099\u2013104.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"509_CR17","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1073\/pnas.202480499","volume":"99","author":"G Asher","year":"2002","unstructured":"Asher G, Lotem J, Sachs L, Kahana C, Shaul Y. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci U S A. 2002;99:13125\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"509_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mrfmmm.2004.05.023","volume":"555","author":"P Nioi","year":"2004","unstructured":"Nioi P, Hayes JD. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat Res. 2004;555:149\u201371.","journal-title":"Mutat Res"},{"key":"509_CR19","first-page":"339","volume":"9","author":"AM Rauth","year":"1997","unstructured":"Rauth AM, Goldberg Z, Misra V. DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis. Oncol Res. 1997;9:339\u201349.","journal-title":"Oncol Res"},{"key":"509_CR20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00008571-199508000-00003","volume":"5","author":"EA Rosvold","year":"1995","unstructured":"Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics. 1995;5:199\u2013206.","journal-title":"Pharmacogenetics"},{"key":"509_CR21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/bjc.1997.11","volume":"5","author":"RD Traver","year":"1997","unstructured":"Traver RD, Siegel D, Beall HD, et al. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer. 1997;5:69\u201375.","journal-title":"Br J Cancer"},{"key":"509_CR22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00008571-199902000-00015","volume":"9","author":"D Siegel","year":"1999","unstructured":"Siegel D, McGuinness SM, Winski, et al. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics. 1999;9:113\u201321.","journal-title":"Pharmacogenetics"},{"key":"509_CR23","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1054\/bjoc.2000.1359","volume":"83","author":"V Misra","year":"2000","unstructured":"Misra V, Grondin A, Klamut HJ, et al. Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity. Br J Cancer. 2000;83:998\u20131002.","journal-title":"Br J Cancer"},{"key":"509_CR24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/bjc.1995.373","volume":"72","author":"BL Kuehl","year":"1995","unstructured":"Kuehl BL, Paterson JW, Peacock JW, et al. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer. 1995;72:555\u201361.","journal-title":"Br J Cancer"},{"key":"509_CR25","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3748\/wjg.v9.i7.1390","volume":"9","author":"JH Zhang","year":"2003","unstructured":"Zhang JH, Li Y, Wang R, et al. NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J Gastroenterol. 2003;9:1390\u20133.","journal-title":"World J Gastroenterol"},{"key":"509_CR26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mrfmmm.2005.06.018","volume":"593","author":"EM Logt van der","year":"2006","unstructured":"van der Logt EM, Bergevoet SM, Roelofs HM, et al. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colon cancer. Mutat Res. 2006;593:39\u201349.","journal-title":"Mutat Res"},{"key":"509_CR27","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/sj.bjc.6601779","volume":"90","author":"HJ Menzel","year":"2004","unstructured":"Menzel HJ, Sarmanova J, Soucek P, et al. Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer. 2004;90:1989\u201394.","journal-title":"Br J Cancer"},{"key":"509_CR28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00008571-199706000-00008","volume":"7","author":"WA Schulz","year":"1997","unstructured":"Schulz WA, Krummeck A, Rosinger I, et al. Increased frequency of a null-allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics. 1997;7:235\u20139.","journal-title":"Pharmacogenetics"},{"key":"509_CR29","first-page":"5913","volume":"60","author":"DJ Long 2nd","year":"2000","unstructured":"Long 2nd DJ, Waikel RL, Wang XJ, et al. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Res. 2000;60:5913\u20135.","journal-title":"Cancer Res"},{"key":"509_CR30","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/jnci\/93.15.1166","volume":"93","author":"DJ Long 2nd","year":"2001","unstructured":"Long 2nd DJ, Waikel RL, Wang XJ, Roop DR, Jaiswal AK. NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. J Natl Cancer Inst. 2001;93:1166\u201370.","journal-title":"J Natl Cancer Inst"},{"key":"509_CR31","first-page":"1051","volume":"11","author":"H Akkiz","year":"2010","unstructured":"Akkiz H, Bayram S, Bekar A, et al. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects. Asian Pac J Cancer Prev. 2010;11:1051\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"509_CR32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","volume":"6","author":"PA Farazi","year":"2006","unstructured":"Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674\u201387.","journal-title":"Nat Rev Cancer"},{"key":"509_CR33","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557\u201376.","journal-title":"Gastroenterology"},{"key":"509_CR34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00125817-200203000-00003","volume":"4","author":"DW Nebert","year":"2002","unstructured":"Nebert DW, Roe AL, Vandale SE, et al. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med. 2002;4:62\u201370.","journal-title":"Genet Med"},{"key":"509_CR35","first-page":"3939","volume":"62","author":"N Iizuka","year":"2002","unstructured":"Iizuka N, Oka M, Yamada-Okabe H, et al. Comparison of gene expression profiles between hepatitis Bvirus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 2002;62:3939\u201344.","journal-title":"Cancer Res"},{"key":"509_CR36","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1073\/pnas.98.3.1188","volume":"98","author":"G Asher","year":"2001","unstructured":"Asher G, Lotem J, Cohen B, et al. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci U S A. 2001;98:1188\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"509_CR37","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1158\/0008-5472.CAN-07-0323","volume":"67","author":"X Gong","year":"2007","unstructured":"Gong X, Kole L, Iskander K, et al. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53. Cancer Res. 2007;67:5380\u20138.","journal-title":"Cancer Res"},{"key":"509_CR38","first-page":"3030","volume":"62","author":"DJ Long 2nd","year":"2002","unstructured":"Long 2nd DJ, Gaikwad A, Multani A, et al. Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res. 2002;62:3030\u20136.","journal-title":"Cancer Res"},{"key":"509_CR39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s101470200013","volume":"7","author":"N Hamajima","year":"2002","unstructured":"Hamajima N, Matsuo K, Iwata H, et al. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol. 2002;7:103\u20138.","journal-title":"Int J Clin Oncol"},{"key":"509_CR40","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.oraloncology.2005.05.004","volume":"41","author":"A Begleiter","year":"2005","unstructured":"Begleiter A, Norman A, Leitao D, et al. Role of NQO1 polymorphisms as risk factors for squamous cell carcinoma of the head and neck. Oral Oncol. 2005;41:927\u201333.","journal-title":"Oral Oncol"},{"key":"509_CR41","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1007\/s00420-002-0353-1","volume":"75","author":"P Soucek","year":"2002","unstructured":"Soucek P, Sarmanova J, Kristensen VN, et al. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas. Int Arch Occup Environ Health. 2002;75:S86\u201392.","journal-title":"Int Arch Occup Environ Health"},{"key":"509_CR42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.gim.0000177530.55043.c1","volume":"7","author":"C Kiyohara","year":"2005","unstructured":"Kiyohara C, Yoshimasu K, Takayama K, et al. NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med. 2005;7:463\u201378.","journal-title":"Genet Med"},{"key":"509_CR43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ijc.11430","volume":"107","author":"M Sarbia","year":"2003","unstructured":"Sarbia M, Bitzer M, Siegel D, et al. Association between NAD(P)H: quinoneoxidoreductase 1 (NQO1) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int J Cancer. 2003;107:381\u20136.","journal-title":"Int J Cancer"},{"key":"509_CR44","first-page":"3091","volume":"12","author":"Y Liu","year":"2011","unstructured":"Liu Y, Zhang D. The NQO1 C609T polymorphism and risk of lung cancer: a meta-analysis. Asian Pac J Cancer Prev. 2011;12:3091\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"509_CR45","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/dna.2011.1332","volume":"31","author":"Z Wang","year":"2012","unstructured":"Wang Z, Hu J, Zhong J. Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C>T polymorphism with esophageal cancer risk. DNA Cell Biol. 2012;31:560\u20137.","journal-title":"DNA Cell Biol"},{"key":"509_CR46","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1478-3231.2012.02787.x","volume":"32","author":"X Wang","year":"2012","unstructured":"Wang X, Zhang X, Qiu B, et al. MDM2 SNP309T>G polymorphism increases susceptibility to hepatitis B virus-related hepatocellular carcinoma in a northeast Han Chinese population. Liver Int. 2012;32:1172\u20138.","journal-title":"Liver Int"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-012-0509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-012-0509-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-012-0509-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T15:05:08Z","timestamp":1594652708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-012-0509-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,13]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1007\/s13277-012-0509-x","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,13]]}}}